tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bright Minds price target raised to $82 from $75 at Baird
PremiumThe FlyBright Minds price target raised to $82 from $75 at Baird
2M ago
Psychedelic: Compass Pathways, GH Research report Q3 earnings
Premium
The Fly
Psychedelic: Compass Pathways, GH Research report Q3 earnings
2M ago
Bright Minds Biosciences’ Promising Pipeline and Strategic Expansion Justify Buy Rating
Premium
Ratings
Bright Minds Biosciences’ Promising Pipeline and Strategic Expansion Justify Buy Rating
3M ago
Bright Minds says BMB-201 outperforms sumatriptan in preclinical model
PremiumThe FlyBright Minds says BMB-201 outperforms sumatriptan in preclinical model
4M ago
Bright Minds Biosciences: Advancing Breakthrough Epilepsy Treatment with BMB-101 and Strong Financial Position
Premium
Ratings
Bright Minds Biosciences: Advancing Breakthrough Epilepsy Treatment with BMB-101 and Strong Financial Position
4M ago
Bright Minds Biosciences Reports Q3 2025 Financial Results
Premium
Company Announcements
Bright Minds Biosciences Reports Q3 2025 Financial Results
4M ago
Bright Minds Biosciences’ BMB-101: A Promising Breakthrough in Treatment-Resistant Epilepsy
PremiumRatingsBright Minds Biosciences’ BMB-101: A Promising Breakthrough in Treatment-Resistant Epilepsy
7M ago
Bright Minds Biosciences: Buy Rating Issued on Promising Potential of BMB-101 for Absence Seizures
Premium
Ratings
Bright Minds Biosciences: Buy Rating Issued on Promising Potential of BMB-101 for Absence Seizures
7M ago
Bright Minds Biosciences Hosts Virtual R&D Day on Absence Epilepsy
Premium
Company Announcements
Bright Minds Biosciences Hosts Virtual R&D Day on Absence Epilepsy
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100